A citation-based method for searching scientific literature

María Teresa Julián, Núria Alonso, Roger Colobran, Alex Sánchez, Antoni Miñarro, Irma Pujol-Autonell, Jorge Carrascal, Silvia Rodríguez-Fernández, Rosa María Ampudia, Marta Vives-Pi, Manel Puig-Domingo. Mol Cell Endocrinol 2016
Times Cited: 7







List of co-cited articles
41 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Dipeptidyl peptidase 4 inhibitor sitagliptin maintains β-cell function in patients with recent-onset latent autoimmune diabetes in adults: one year prospective study.
Yunjuan Zhao, Lin Yang, Yufei Xiang, Lingjiao Liu, Gan Huang, Zhaofeng Long, Xia Li, R David Leslie, Xiangbing Wang, Zhiguang Zhou. J Clin Endocrinol Metab 2014
74
42

The DPP4 inhibitor linagliptin delays the onset of diabetes and preserves β-cell mass in non-obese diabetic mice.
Jacob Jelsing, Niels Vrang, Søren B van Witteloostuijn, Michael Mark, Thomas Klein. J Endocrinol 2012
38
28

The physiology of glucagon-like peptide 1.
Jens Juul Holst. Physiol Rev 2007
28

Reversal of new-onset diabetes through modulating inflammation and stimulating beta-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor.
Lei Tian, Jie Gao, Jianqiang Hao, Yu Zhang, Huimin Yi, Timothy D O'Brien, Robert Sorenson, Jian Luo, Zhiguang Guo. Endocrinology 2010
89
28

Vildagliptin induces β-cell neogenesis and improves the lipid profile in a later phase of type 1 diabetes.
Pedro H de Amorim Miranda, Otávio M Monteiro, Joamyr V Rossoni, Marcelo E Silva, Wanderson G de Lima, Daniela C Costa. Curr Pharm Biotechnol 2015
6
33

Higher serum DPP-4 enzyme activity and decreased lymphocyte CD26 expression in type 1 diabetes.
Tímea Varga, Anikó Somogyi, Gábor Barna, Barna Wichmann, Géza Nagy, Károly Rácz, László Selmeci, Gábor Firneisz. Pathol Oncol Res 2011
40
28

Dipeptidyl peptidase IV inhibitor treatment stimulates beta-cell survival and islet neogenesis in streptozotocin-induced diabetic rats.
J Andrew Pospisilik, Jennifer Martin, Timothy Doty, Jan A Ehses, Nathalie Pamir, Francis C Lynn, Shalea Piteau, Hans-Ulrich Demuth, Christopher H S McIntosh, Raymond A Pederson. Diabetes 2003
273
28

Extension of the CD4⁺Foxp3⁺CD25(-/low) regulatory T-cell subpopulation in type 1 diabetes mellitus.
András Zóka, Gábor Barna, Anikó Somogyi, Györgyi Műzes, Ágnes Oláh, Zahra Al-Aissa, Orsolya Hadarits, Katalin Kiss, Gábor Firneisz. Autoimmunity 2015
16
28

C-peptide levels in latent autoimmune diabetes in adults treated with linagliptin versus glimepiride: exploratory results from a 2-year double-blind, randomized, controlled study.
Odd Erik Johansen, Bernhard O Boehm, Valdemar Grill, Peter A Torjesen, Sudipta Bhattacharya, Sanjay Patel, Kristiane Wetzel, Hans-Juergen Woerle. Diabetes Care 2014
41
28

Significant elevation of serum dipeptidyl peptidase-4 activity in young-adult type 1 diabetes.
Saeko Osawa, Dan Kawamori, Naoto Katakami, Mitsuyoshi Takahara, Fumie Sakamoto, Takashi Katsura, Tetsuyuki Yasuda, Hideaki Kaneto, Munehide Matsuhisa, Taka-Aki Matsuoka,[...]. Diabetes Res Clin Pract 2016
18
28

Combining MK626, a novel DPP-4 inhibitor, and low-dose monoclonal CD3 antibody for stable remission of new-onset diabetes in mice.
Lei Ding, Conny A Gysemans, Geert Stangé, Yves Heremans, Yixing Yuchi, Tatiana Takiishi, Hannelie Korf, Marie Chintinne, Richard D Carr, Harry Heimberg,[...]. PLoS One 2014
15
28


Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo.
A Steinbrecher, D Reinhold, L Quigley, A Gado, N Tresser, L Izikson, I Born, J Faust, K Neubert, R Martin,[...]. J Immunol 2001
124
28

Reduction of serum soluble CD26/dipeptidyl peptidase IV enzyme activity and its correlation with disease activity in systemic lupus erythematosus.
Hiroshi Kobayashi, Osamu Hosono, Tsuneyo Mimori, Hiroshi Kawasaki, Nam Hoang Dang, Hirotoshi Tanaka, Chikao Morimoto. J Rheumatol 2002
52
28

CD26/dipeptidyl peptidase 4-deficiency alters thymic emigration patterns and leukcocyte subsets in F344-rats age-dependently.
C Klemann, J Schade, R Pabst, S Leitner, J Stiller, S von Hörsten, M Stephan. Clin Exp Immunol 2009
30
28

Sitagliptin inhibit human lymphocytes proliferation and Th1/Th17 differentiation in vitro.
Marcelo Maia Pinheiro, Caroline Lais Stoppa, Claudete Justina Valduga, Cristina Eunice Okuyama, Renata Gorjão, Regina Mara Silva Pereira, Susana Nogueira Diniz. Eur J Pharm Sci 2017
40
28

Low DPP4 expression and activity in multiple sclerosis.
Marta Tejera-Alhambra, Armanda Casrouge, Clara de Andrés, Rocío Ramos-Medina, Bárbara Alonso, Janet Vega, Matthew L Albert, Silvia Sánchez-Ramón. Clin Immunol 2014
22
28

Is there an association between dipeptidyl peptidase-4 inhibitors and autoimmune disease? A population-based study.
Khalaf Kridin, Kyle Amber, Mogher Khamaisi, Doron Comaneshter, Erez Batat, Arnon D Cohen. Immunol Res 2018
21
28

One year remission of type 1 diabetes mellitus in a patient treated with sitagliptin.
Marcos M Lima-Martínez, Ernesto Guerra-Alcalá, Miguel Contreras, José Nastasi, Janelle A Noble, Constantin Polychronakos. Endocrinol Diabetes Metab Case Rep 2014
14
28

Dipeptidyl peptidase IV activity and/or structure homologs: contributing factors in the pathogenesis of rheumatoid arthritis?
Aleksi Sedo, Jonathan S Duke-Cohan, Eva Balaziova, Liliana R Sedova. Arthritis Res Ther 2005
57
28

Circulating CD26 is negatively associated with inflammation in human and experimental arthritis.
Nathalie Busso, Nicolai Wagtmann, Christian Herling, Veronique Chobaz-Péclat, Angelika Bischof-Delaloye, Alexander So, Eric Grouzmann. Am J Pathol 2005
158
28


Possible Long-Term Efficacy of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Slowly Progressive Type 1 Diabetes (SPIDDM) in the Stage of Non-Insulin-Dependency: An Open-Label Randomized Controlled Pilot Trial (SPAN-S).
Takuya Awata, Akira Shimada, Taro Maruyama, Yoichi Oikawa, Nobuyuki Yasukawa, Susumu Kurihara, Yumi Miyashita, Masako Hatano, Yuichi Ikegami, Masafumi Matsuda,[...]. Diabetes Ther 2017
25
28

Dipeptidyl Peptidase-4 Inhibitor Anagliptin Prevents Intracranial Aneurysm Growth by Suppressing Macrophage Infiltration and Activation.
Taichi Ikedo, Manabu Minami, Hiroharu Kataoka, Kosuke Hayashi, Manabu Nagata, Risako Fujikawa, Sei Higuchi, Mika Yasui, Tomohiro Aoki, Miyuki Fukuda,[...]. J Am Heart Assoc 2017
32
28

Functional role of CD26 on human B lymphocytes.
F Bühling, U Junker, D Reinhold, K Neubert, L Jäger, S Ansorge. Immunol Lett 1995
90
28



Dipeptidyl peptidase expression during experimental colitis in mice.
Roger Yazbeck, Melanie L Sulda, Gordon S Howarth, Andre Bleich, Kerstin Raber, Stephan von Hörsten, Jens Juul Holst, Catherine A Abbott. Inflamm Bowel Dis 2010
32
28


Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation.
Dirk Reinhold, Aliza Biton, Stefanie Pieper, Uwe Lendeckel, Jürgen Faust, Klaus Neubert, Ute Bank, Michael Täger, Siegfried Ansorge, Stefan Brocke. Int Immunopharmacol 2006
37
28

TMPRSS2 and COVID-19: Serendipity or Opportunity for Intervention?
Konrad H Stopsack, Lorelei A Mucci, Emmanuel S Antonarakis, Peter S Nelson, Philip W Kantoff. Cancer Discov 2020
188
28

COVID-19: Melatonin as a potential adjuvant treatment.
Rui Zhang, Xuebin Wang, Leng Ni, Xiao Di, Baitao Ma, Shuai Niu, Changwei Liu, Russel J Reiter. Life Sci 2020
249
28


Hypocortisolism in survivors of severe acute respiratory syndrome (SARS).
Melvin Khee-Shing Leow, Daniel Seow-Khee Kwek, Alan Wei-Keong Ng, Kian-Chung Ong, Gregory Jon-Leng Kaw, Lawrence Soon-U Lee. Clin Endocrinol (Oxf) 2005
117
28

Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice.
Kun Li, Christine L Wohlford-Lenane, Rudragouda Channappanavar, Jung-Eun Park, James T Earnest, Thomas B Bair, Amber M Bates, Kim A Brogden, Heather A Flaherty, Tom Gallagher,[...]. Proc Natl Acad Sci U S A 2017
101
28

Oxytocin-secreting system: A major part of the neuroendocrine center regulating immunologic activity.
Ping Wang, Hai-Peng Yang, Shujun Tian, Liwei Wang, Stephani C Wang, Fengmin Zhang, Yu-Feng Wang. J Neuroimmunol 2015
39
28

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC.
V Stalin Raj, Huihui Mou, Saskia L Smits, Dick H W Dekkers, Marcel A Müller, Ronald Dijkman, Doreen Muth, Jeroen A A Demmers, Ali Zaki, Ron A M Fouchier,[...]. Nature 2013
28

COVID-19 and the endocrine system: exploring the unexplored.
R Pal, M Banerjee. J Endocrinol Invest 2020
88
28

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Markus Hoffmann, Hannah Kleine-Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra Erichsen, Tobias S Schiergens, Georg Herrler, Nai-Huei Wu, Andreas Nitsche,[...]. Cell 2020
28

Oxytocin as a potential defence against Covid-19?
Amélie Soumier, Angela Sirigu. Med Hypotheses 2020
9
28

Regulation and roles of CD26/DPPIV in hematopoiesis and diseases.
Zeynab Aliyari Serej, Abbas Ebrahimi Kalan, Ahmad Mehdipour, Hojjatollah Nozad Charoudeh. Biomed Pharmacother 2017
14
28



A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing β-cell replication and neogenesis.
Jae Min Cho, Hye Won Jang, Hwanju Cheon, Yeon Taek Jeong, Do-Hoon Kim, Yu-Mi Lim, Song-Hyen Choi, Eun-Kyoung Yang, Chang-Yell Shin, Moon Ho Son,[...]. Diabetes Res Clin Pract 2011
41
14


Increasing incidence of type 1 diabetes among Korean children and adolescents: analysis of data from a nationwide registry in Korea.
Jae Hyun Kim, Chong Guk Lee, Young Ah Lee, Sei Won Yang, Choong Ho Shin. Pediatr Diabetes 2016
33
14

Increasing incidence of type 1 diabetes in youth: twenty years of the Philadelphia Pediatric Diabetes Registry.
Terri H Lipman, Lorraine E Levitt Katz, Sarah J Ratcliffe, Kathryn M Murphy, Alexandra Aguilar, Iraj Rezvani, Carol J Howe, Shruti Fadia, Elizabeth Suarez. Diabetes Care 2013
77
14


The treatment of type 1 diabetes mellitus with agents approved for type 2 diabetes mellitus.
Kashif M Munir, Stephen N Davis. Expert Opin Pharmacother 2015
11
14

Safety and effectiveness of dipeptidyl peptidase-4 inhibitors versus intermediate-acting insulin or placebo for patients with type 2 diabetes failing two oral antihyperglycaemic agents: a systematic review and network meta-analysis.
Andrea C Tricco, Jesmin Antony, Paul A Khan, Marco Ghassemi, Jemila S Hamid, Huda Ashoor, Erik Blondal, Charlene Soobiah, Catherine H Yu, Brian Hutton,[...]. BMJ Open 2014
29
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.